Sparsentan in IgA nephropathy: a plain language summary of publication for the PROTECT study
Summary What is this summary about? Sparsentan (FILSPARI ® ) is a once-daily pill for people with Immunoglobulin A (IgA) nephropathy who are at high risk for worsening kidney disease. Early results from a research study (clinical trial) called PROTECT showed that after 9 months of treatment, sparsen...
Na minha lista:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publishing
2025-07-01
|
| Colecção: | Therapeutic Advances in Rare Disease |
| Acesso em linha: | https://doi.org/10.1177/26330040251355613 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|